A DLL3-targeted ADC effectively targets pulmonary neuroendocrine tumor-initiating cells to result in sustained tumor regressions Meeting Abstract


Authors: Saunders, L. R.; Bankovich, A. J.; Anderson, W. A.; Aujay, M.; Bheddah, S.; Black, K. A.; Desai, R.; Escarpe, P.; Hampl, J.; Park, A.; Laysang, A.; Liu, D.; Lopez-Molina, J.; Milton, M.; Pysz, M.; Shao, H.; Torgov, M.; Williams, S.; Foord, O.; Howard, P.; Poirier, J. T.; Pietanza, M. C.; Massion, P. P.; Rudin, C. M.; Stull, R. A.; Slingerland, B. S.; Dylla, S. J.
Abstract Title: A DLL3-targeted ADC effectively targets pulmonary neuroendocrine tumor-initiating cells to result in sustained tumor regressions
Meeting Title: 16th World Conference on Lung Cancer (WCLC)
Keywords: sclc; conjugate; tumor-initiating cell; patient-derived xenograft; antibody-drug
Journal Title: Journal of Thoracic Oncology
Volume: 10
Issue: 9 Suppl. 2
Meeting Dates: 2015 Sep 6-9
Meeting Location: Denver, CO
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2015-09-01
Start Page: S362
Language: English
ACCESSION: WOS:000370365101304
PROVIDER: wos
PUBMED: 26710300
DOI: 10.1016/S1556-0864(16)30011-9
Notes: Meeting Abstract: MINI27.09 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria C Pietanza
    122 Pietanza
  2. Charles Rudin
    490 Rudin
  3. John Thomas Poirier
    82 Poirier